Instrumentation Laboratory Class II Recall Z-1533-2026
Summary
The FDA has issued a Class II recall for Instrumentation Laboratory's GEM Premier 5000 device due to an increased incidence of 'Process Control Solution Not Detected' errors. The recall, initiated voluntarily by the firm, affects approximately 8 units distributed worldwide.
What changed
The FDA has classified a recall of Instrumentation Laboratory's GEM Premier 5000 device (Part No. 00055415005) as Class II, indicating that use of or exposure to a problematic product may cause temporary or medically reversible adverse health consequences. The recall, initiated voluntarily by the firm on January 20, 2026, is due to customer complaints of frequent 'Process Control Solution Not Detected' errors during warm-up, leading to GEM PAK ejection and potential operational disruption. Approximately 8 units are affected, with distribution reported worldwide.
While the FDA notes that many GEM PAKs continue to perform as intended and the issue may not necessitate immediate patient reassessment, consecutive ejections can prolong turnaround times. This could delay critical results, potentially impacting patient management. Companies involved in the distribution or use of this device should review their inventory, understand the potential for operational disruption, and ensure appropriate contingency plans are in place to manage any delays in obtaining results. The recall status is currently 'Ongoing'.
What to do next
- Review inventory of GEM Premier 5000 devices and associated GEM PAK cartridges.
- Assess potential for operational disruption due to 'Process Control Solution Not Detected' errors.
- Implement contingency plans to manage potential delays in test results.
Source document (simplified)
json
{
"meta": {
"disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
"terms": "https://open.fda.gov/terms/",
"license": "https://open.fda.gov/license/",
"last_updated": "2026-03-18",
"results": {
"skip": 0,
"limit": 1,
"total": 1
}
},
"results": [
{
"status": "Ongoing",
"city": "Bedford",
"state": "MA",
"country": "United States",
"classification": "Class II",
"openfda": {
},
"product_type": "Devices",
"event_id": "98349",
"recalling_firm": "Instrumentation Laboratory",
"address_1": "180 Hartwell Rd",
"address_2": "N/A",
"postal_code": "01730-2443",
"voluntary_mandated": "Voluntary: Firm initiated",
"initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit",
"distribution_pattern": "Worldwide distribution - US Nationwide and the countries of Argentina, Austria, Australia, Belgium, Bulgaria, Brazil, Belarus, Switzerland, Canada, Chile, China, Colombia, Czech Republic, Germany, Denmark, Dominican Republic, Ecuador, Estonia, Spain, Finland, France, United Kingdom, Georgia, Greece, Guatemala, Hong Kong, Croatia, Hungary, Indonesia, Ireland, Israel, India, Italy, Jordan, Japan, South Korea, Kazakhstan, Lebanon, Lithuania, Luxembourg, Latvia, Macau, Mexico, Malaysia, Netherlands, New Zealand, Oman, Panama, Peru, Philippines, Poland, Portugal, Qatar, Romania, Serbia, Saudi Arabia, Sweden, Singapore, Slovenia, San Marino, South Africa, Thailand, Tunisia, Turkey, Uruguay, Uzbekistan & Vietnam.",
"recall_number": "Z-1533-2026",
"product_description": "GEM Premier 5000; Part No. 00055415005.",
"product_quantity": "8 units",
"reason_for_recall": "Confirmed customer complaints indicating that GEM PAKs (cartridges) for the GEM Premier 5000 may experience an increased incidence of Process Control Solution Not Detected (PCSND) errors during warm-up, including consecutive occurrences, resulting in GEM PAK ejection and requiring insertion of a new GEM PAK. iQM2 is an active quality process control program designed to provide continuous monitoring of the entire testing process. Thus, if a GEM PAK completes AutoPAK Validation following warm-up, it may remain in use. Consecutive GEM PAK ejections during warm-up may prolong turnaround times, potentially delaying results. In such cases, patient management may require reassessment once results are available. While many GEM PAKs continue to perform as intended, consecutive ejections may increase the likelihood of operational disruption, highlighting the importance of advance planning where feasible to help minimize impact.",
"recall_initiation_date": "20260120",
"center_classification_date": "20260310",
"report_date": "20260318",
"code_info": "Part number: 00055415005; UDI: 08426950807667; Lots No. 251125S, 251201AJ, 251212O, 251218V, 251229X."
}
]
}
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Healthcare alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when FDA: Device Recalls Class II publishes new changes.